Close Menu

network modeling

The researchers focused on modeling a signaling pathway that they believe could be a viable target for combination therapies that they hope to explore in clinical trials.

The group will offer free access to omic and clinical data from the project and develop software to help clinicians use the models in patient care.

The strategy could be applied more widely to study the development of other organ systems, and will benefit from new single-cell gene expression analysis technology.

The fifth annual Dialogue on Reverse Engineering Assessment and Methods is seeking participants for the annual evaluation of computational systems biology methods.

Biogen Idec worked with Gene Network Sciences to integrate and analyze genome-wide SNP data, expression data, and clinical data from three time points in more than 70 rheumatoid arthritis patients — a process that ultimately identified several targets, including one "that had not been on the radar screen."

At the Network Biology 2.0 conference, speakers underscored the degree to which the understanding of cancer is being empowered by molecular characterization projects and is accompanied by the desire to select the right populations for clinical trials.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.